You have searched for "infectious diseases"
Showing 1-10 of 3095
BALIK PULAU: A 42-year-old man was handed a RM1,000 compound for violating his home quarantine order by visiting a fair at the Spice Arena Convention Centre here on Friday (Aug 7).
SINGAPORE, Aug 8 (The Straits Times/ANN): Volunteers being screened for Lunar-Cov19's early-stage clinical trial that is set to last till October
BERLIN (Reuters) - The number of confirmed coronavirus cases in Germany increased by 1,122 to 215,336, data from the Robert Koch Institute (RKI) for infectious diseases showed on Saturday.
(Reuters) - An approved coronavirus vaccine could end up being effective only 50-60% of the time, meaning public health measures will still be needed to keep the pandemic under control, Dr. Anthony Fauci, the top U.S. infectious diseases expert, said on Friday.
ROME, Aug. 7 (Xinhua) -- The Lazzaro Spallanzani National Institute for Infectious Diseases in the Italian capital will start human clinical trials of a possible vaccine against the coronavirus in late August, the hospital and local authorities said on Friday.
AMIDST the global race by pharmaceutical companies to develop vaccines for the coronavirus (Covid-19) pandemic, a few local players were thrust into the limelight.
KUALA LUMPUR: The police have finished recording statements from nine individuals regarding the mass gathering of Datuk Seri Najib Razak’s supporters at the Kuala Lumpur Court Complex on July 28.
BERLIN (Reuters) - The number of confirmed coronavirus cases in Germany increased by 1,147 to 214,214, data from the Robert Koch Institute (RKI) for infectious diseases showed on Friday.
HONG KONG (The Straits Times/ANN): The Hong Kong government said late on Thursday (aUG 6) night it would provide free tests to foreign helpers living in boarding houses, after an Indonesian maid who stayed in two dormitories tested positive for Covid-19.
WASHINGTON, Aug. 6 (Xinhua) -- The U.S. National Institutes of Health (NIH) announced on Thursday the start of a randomized, controlled clinical trial evaluating the safety and efficacy of a treatment regimen consisting of the antiviral remdesivir plus the immunomodulator interferon beta-1a in COVID-19 patients.